Woman in her 40s in Western Australia reported to be in hospital in a stable condition after developing clot
Health authorities have concluded a second case of a rare blood clot syndrome in Australia “is likely” linked to the AstraZeneca vaccine.
The case occurred in a woman in her 40s who received the AstraZeneca Covid-19 jab in Western Australia, the Therapeutic Goods Administration announced on Tuesday. She is receiving treatment in hospital and is in a stable condition.
Related: AstraZeneca blood clotting: what is this rare syndrome and how is it caused?
Related: Australia won’t buy Johnson & Johnson’s one-dose Covid vaccine due to AstraZeneca similarities
severe or persistent headache or blurred vision
shortness of breath, chest pain, leg swelling or persistent abdominal pain; or
unusual skin bruising and/or pinpoint round spots beyond the site of injection.
